Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
30.26
+0.20 (0.67%)
At close: Jul 31, 2025, 4:00 PM
30.26
0.00 (0.00%)
After-hours: Jul 31, 2025, 4:10 PM EDT

KNSA Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2020
2,2421,4281,2341,0428111,203
Upgrade
Market Cap Growth
52.14%15.76%18.45%28.46%-32.59%98.17%
Upgrade
Enterprise Value
1,9591,2151,046848617840
Upgrade
Last Close Price
30.0619.7817.5414.9811.7717.67
Upgrade
PE Ratio
458.23-87.605.68--
Upgrade
Forward PE
20.7942.93----
Upgrade
PS Ratio
4.123.374.574.7321.04-
Upgrade
PB Ratio
4.503.262.812.634.383.86
Upgrade
P/TBV Ratio
4.713.382.932.764.893.86
Upgrade
P/FCF Ratio
33.9556.2093.67182.67--
Upgrade
P/OCF Ratio
33.7255.5992.76179.37--
Upgrade
EV/Sales Ratio
3.702.873.873.8516.02-
Upgrade
EV/EBITDA Ratio
327.81--69.62--
Upgrade
EV/EBIT Ratio
437.83--86.73--
Upgrade
EV/FCF Ratio
29.4747.8179.39148.64--
Upgrade
Debt / Equity Ratio
0.020.020.030.020.030.02
Upgrade
Debt / EBITDA Ratio
0.91--0.38--
Upgrade
Debt / FCF Ratio
0.150.390.931.04--
Upgrade
Asset Turnover
0.880.770.550.640.13-
Upgrade
Inventory Turnover
5.986.583.413.72--
Upgrade
Quick Ratio
2.882.843.584.484.1510.16
Upgrade
Current Ratio
3.573.304.345.164.3810.46
Upgrade
Return on Equity (ROE)
1.03%-9.85%3.37%63.10%-63.55%-60.07%
Upgrade
Return on Assets (ROA)
0.46%-5.15%-3.19%1.76%-33.63%-32.57%
Upgrade
Return on Capital (ROIC)
0.59%-6.34%-3.69%2.06%-38.39%-35.96%
Upgrade
Return on Capital Employed (ROCE)
0.80%--2.40%--
Upgrade
Earnings Yield
0.21%-3.02%1.14%17.60%-19.48%-13.42%
Upgrade
FCF Yield
2.95%1.78%1.07%0.55%-15.63%-11.37%
Upgrade
Buyback Yield / Dilution
-5.61%0.69%-2.13%-2.69%-10.89%-14.42%
Upgrade
Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q